Dr. Kat McCormick is the CEO of InVivo Biosystems, a biotechnology company that provides innovative solutions for genetic research and drug discovery. She co-founded InVivo Biosystems and created the first product, a platform that enables high-throughput phenotyping of gene expression in living organisms. She leads the scientific strategy, product vision, and customer engagement for the company, expanding its portfolio to new markets and applications. She is also an active contributor to the scientific community. She is passionate about advancing the understanding and treatment of neurological diseases, and empowering researchers with cutting-edge tools and technologies.